You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

145 Items

Epirubicin, as a Single Agent or in Combination, for Metastatic Breast Cancer

Document Status: Archived
ID: 1-6

Sep 2011

Fluoropyrimidine Treatment in Patients with Dihydropyrimidine Dehydrogenase (DPD) Deficiency: Guidance for Clinicians

Document Status: Current
Version: 1

Apr 2023

Follow-Up Model of Care for Cancer Survivors: Recommendations for the Delivery of Follow-up Care for Cancer Survivors in Ontario

Document Status: Current
ID: N/A
Version: N/A

Mar 2019

Fulvestrant for Systemic Therapy of Locally Advanced or Metastatic Breast Cancer in Postmenopausal Women: Guideline Recommendations

Document Status: Archived
ID: 1-13

Sep 2008

Guidance on the Substitution of Systemic Therapy Agents

Document Status: Current
ID: GL-C50-33
Version: 1

Aug 2017

Hepatitis B Virus Screening and Management for Patients Receiving Systemic Treatment

Document Status: Current

Sep 2022

Ifosfamide-based Combination Chemotherapy in Advanced Soft Tissue Sarcoma

Document Status: Archived
ID: 11-4

Sep 2011

Indications for Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery

Document Status: Current
ID: GL 17-12
Version: N/A

Sep 2019

Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-Line Chemotherapy

Document Status: In-Review
ID: 7-13

Oct 2017

Kadcyla® Trastuzumab Emtansine Safety Reminder

Document Status: Current
ID: GL-C50-15

Jun 2014

Liposomal Anthracyclines in the Management of HIV-positive Kaposi's Sarcoma

Document Status: Archived
ID: 12-8
Version: 2

Jun 2013

Locoregional Management of In-Transit Metastasis in Melanoma

Document Status: Current
ID: GL 8-10
Version: N/A

Feb 2020